Investigation Launched into Agiliti Inc.'s Acquisition Fairness by Levi & Korsinsky, LLP

New York-based law firm, Levi & Korsinsky, LLP, has initiated an investigation into the proposed acquisition of Agiliti Inc. AGTI by Thomas H. Lee Partners, L.P., urging all shareholders of Agiliti to review the sale's fairness. The focus of the investigation is to determine whether Agiliti's board of directors is acting in the best interests of AGTI shareholders, and whether the sale price is both fair and reasonable.

Background of Agiliti Inc.

Agiliti Inc. operates within the healthcare sector, providing key technology management and service solutions across the United States. Based in Minneapolis, Minnesota, Agiliti has carved out a niche in furnishing the healthcare industry with vital equipment, services, and support. The company's stock, listed on the NYSE under the ticker AGTI, has garnered attention due to its industry prominence and contribution to healthcare technology infrastructure.

Details on the Acquisition Investigation

Levi & Korsinsky's alert to AGTI shareholders, specifically those who purchased stock prior to February 26, 2024, marks a significant moment, revealing potential concerns over the acquisition's equity. As investor rights advocates, the firm is committed to ensuring all procedures abide by legal and ethical regulations, and that shareholder value is maintained throughout such pivotal transitions.

Comparison to Catalent, Inc.

In contrast to Agiliti's healthcare service and technology focus, Catalent, Inc. CTLT, as a multinational corporation, provides extensive services in drug delivery, development, manufacturing, and various therapies. Headquartered in Somerset, New Jersey, Catalent is a powerhouse in the pharmaceutical and biotech service industry, showcasing how diverse healthcare-related companies can be within the stock market.

The legal investigation into Agiliti's acquisition serves to underscore the complexities and due diligence required in such corporate maneuvers. It is a scenario reminiscent of the stringent oversight that accompanies mergers and acquisitions involving major players like Catalent and other similar entities.

Investigation, Acquisition, Shareholder